|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current assets: | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Prepaid expenses and other current assets | |||||||
| Total current assets | |||||||
| Cash and marketable securities held in Trust Account | |||||||
| Other assets | |||||||
| Prepaid expenses and other assets | |||||||
| Total assets | |||||||
| Liabilities and Stockholder's Equity (Deficit) | |||||||
| Current liabilities: | |||||||
| Accounts payable and accrued expenses | |||||||
| Sponsor loans (note 4) | |||||||
| Other current liabilities | |||||||
| Total current liabilities | |||||||
| Noncurrent liabilities: | |||||||
| Warrants | |||||||
| Public Warrants | |||||||
| Forward Purchase Warrants | |||||||
| Private Placement Warrants | |||||||
| Forward Purchase Agreement | |||||||
| Deferred offering costs | |||||||
| Total liabilities | |||||||
| Common stock subject to possible redemption, 57,500,000 shares at redemption value | |||||||
| Stockholder's equity (deficit): | |||||||
| Common stock | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total stockholder's equity (deficit) | |||||||
| Total liabilities and stockholder's equity (deficit) |
Loading...